MedTrace Logo

Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1

NCT00265278 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-01-11

No results posted yet for this study

Summary

The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral Modafinil.

Conditions

  • Amphetamine-Related Disorders

Interventions

DRUG

Modafinil

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Reese Jones, M.D. · Langley Porter Psychiatric Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Completion
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00265278 on ClinicalTrials.gov